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The immunization of rats against Pneumococcus Type I, by feeding 
the soluble specific substance has been reported in the preceding paper 
of this  series  (1).  It  was desirable  to  know whether an analogous 
effect could be obtained by the oral administration of the specific sub- 
stance of Types II and III.  This seemed probable since the conditions 
under which the immunity to these three types of pneumococci by 
oral  administration of the organisms is obtained,  are  very similar. 
For example, 1 or 2  feedings of the dead bacteria from 5 cc. growth 
are sufficient to protect rats against any of these three types.  The 
effect is evident in 48 hours for all of these types.  Furthermore, the 
Berkefeld filtrates of sodium glycocholate-dissolved Types II and III 
pneumococci will protect against the homologous types, just  as  the 
corresponding solution of Type I  does (2). 
When the specific substance of Type I was fed to rats, the percentage 
of animals protected was, in general, smaller than when  the  whole 
organism or  the  dissolved cell  was  used,  although in  some of  the 
experiments the results were so like those obtained when the bacteria 
are employed as to be indistinguishable from them.  It was expected 
that a  similar difference would probably exist between the effects of 
feeding the specific polysaccharides of Types II and III and the cor- 
responding organisms, in  the  event that  the former were found to 
confer an immunity.  Such a difference, however, would make it more 
difficult  to  secure  convincing evidence  for  these  types,  since  the 
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1 IMMUNITY  TO  PNEIYMOCOCCUS  II AND  III 
increased  resistance which follows the ingestion of  Types II and III 
pneumococci is not so great as it is in the case of Type I.  The varia- 
tion in resistance to Types II and III among normal rats, referred to 
in an earlier paper  (2),  was also expected to add to the difficulty. 
The  present  data  record  the  results  of  experiments  in  which  the 
resistance  of  rats  to  Types  II  and  III  pneumococci,  following  the 
ingestion  of the  corresponding soluble specific substances, was meas- 
ured.  Several  experiments  in  which  the  Type I  specific  substance 
was fed  and  the  resistance  to Types II and  III  was measured,  and 
several in which the resistance to Type I  was determined after feeding 
the polysaccharides of Types II and III, are also included. 
Methods 
The Soluble Specific Substance of Types H  and III Pneumococcus.--Chemical 
analysis 1 of the Type II specific substance  yielded  the following figures:--C  = 
45.1 per cent,  H  =  6.4 per cent,  ash  =  2.3 per cent (all on dry basis),  loss on 
heating at 100°C. = 9.7 per cent.  For Type III, the result~were:--C =  42.8 per 
cent, H  =  5.7 per cent,  ash  =  1.7 per cent (all on dry basis), loss on heating at 
100°C. =  6.7 per cent.  The Type II substance  was  white  in  color;  the  Type 
III slightly yellow.  The biuret, xanthoproteic and Millon tests were negative for 
both substances.  A concentration  of 1 part of either in 3,000,000 of water  could 
be detected by means of antisera. 
For feeding, the Type II specific substance  was dissolved in water; the Type III 
in N/10 NaOH, followed by neutralization  with ~r/10 HC1.  The solutions  were 
mixed with either milk or cracker meal, and the rats were fed individually.  The 
resistance  of the animals to the pneumococcus was measured by injecting  graded 
doses of the organisms  intraperitoneally,  in  a  volume  of 0.2  co.  The amounts 
injected ranged from 10  -8 to 10  -~ co. of an 18 hour blood broth culture. 
Owing to the fact that the resistance of different untreated rats to Types II and 
III pneumococcus  is  so  unlike,  the  experiments  were always done  with  single 
fitters,  half of the litter being used  for controls,  the other half for experimental 
animals.  Even this precaution does not always avoid the irregularity  in deaths 
among controls injected with Type II.  It was also found essential to use healthy 
rats. 
Feeding the Type H  Specific Substame 
Experiment/.--Each treated  (E)  rat received 0.5 rag. on each of 2 successive 
days.  Test took place  2 days after the 2nd feeding.  Of 12 rats in each group, 
6 died among the controls and 3 among the treated rats (Table I). 
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Experiment 2.--Each E rat received 0.5 mg. on each of 2 successive days.  Test 
took place 2 days after the 2nd feeding.  Of 12 rats in each group, 4 died among the 
controls and 5 among the treated animals (Table I). 
Experiment 3.--Each E rat was fed 0.5 mg. on each of 2 successive days.  Test 
was done 3 days after the 2nd dose.  Of 12 rats in each group, there were 8 deaths 
among the controls and 9 among the treated animals (Table I). 
Experiment 4.--Each E  rat was fed 1 rag. on each of 2 successive days and the 
test  was done 3  days after  the  2nd dose.  There were 4  deaths  among the  12 
controls and 2 among the 11 treated rats (Table I). 
The  results  of  these  four  experiments  gave  no  evidence  for  any 
immunity following the ingestion of 1 or 2  rag. of the soluble  specific 
substance of Type II pneumococcus.  26 out of 48 controls and 28 out 
of 47  treated  animals  survived.  The purified  sample  used  had  been 
prepared from an autolyzed solution of the organisms.  It was decided 
to try the effect of feeding the specific substance prepared in a different 
way. 
Desiccated Type II organisms were disrupted in a  pebble  mill.  0.1  normal 
HCI was added (50 cc. for the growth from 5 1.) and the mixture was shaken  in a 
machine  for  8  hours.  This  was  allowed  to  settle  and  then  was  centrifuged. 
Normal NaOH was added till almost neutral.  A  heavy,  precipitate settles  out. 
After centrifugation,  another drop or two of alkali was added  to complete  the 
precipitation of protein.  An excess of alkali must be avoided in order not to redis- 
solve  this  precipitate.  Following  centrifugation,  normal  NaOH  was  added  to 
make 1~1/10 and nine volumes of 95 per cent ethyl alcohol poured in.  After stand- 
ing overnight, the precipitate was removed by centrifugation and  dissolved in 10 
to 12 cc. of water.  The insoluble portion was discarded.  Normal HC1 was added 
to the solution to make N/15, and after  the addition of nine volumes of alcohol, 
the whole was left overnight in an ice box.  After centrifuging, the precipitate was 
dissolved in 10 cc. water.  Any insoluble matter present was removed by centri- 
fugation.  The solution gave a  slightly positive biuret  test,  and judging by the 
intensity of the precipitin reactions which were done with serial dilutions, contained 
about 2 rag. of the specific  substance for the desiccated material representing  11. 
of culture.  Five experiments  were done with three such preparations. 
Experiment 5.--Each E  rat received the S.S.S.  solution equivalent to 100 cc. 
growth on each of 3 successive days.  Test was done 2 days after the 3rd feeding. 
Of 12 controls, 9 died; of 12 treated rats, 5 died (Table I). 
Experiment 6.--Each E  rat  received the  S.S.S.  solution equivalent  to 66 cc. 
growth on each of 3 successive days and the test took place 2 days after the 3rd 
feeding.  8 of 12 controls and 6 out of 12 treated animals died (Table I). 
Experiment 7.--Each E  rat  was fed the  S.S.S.  solution equivalent  to 66  co. IMMUNITY  TO  PNEITMOCOCCUS  II  AND  III 
TABLE  I 
Resistance to Pneumococcus Type II, Following Ingestion  of the Soluble Specific 
Substance 
Litter  1  Litter  2  Litter  3 
Experiment  Dose  C  E  C  E  C  E 
¢c.  gm.  gm.  gm.  gm.  gm.  gm. 
10  -8  32  S  32  2  27  S  27  S  29  S  28  S 
10  -7  33  S  33  S  29  I  2  28  S  31  S  31  S 
10  -e  36  7  37  S  30  2  28  S  36  2  34  S 
10  -s  36  2  38  2  31  2  32  2  35  S  37  S 
10  -8  27  3  27  3  26  S  28  S  46  S  31  S 
10  -7  31  2  30  S  28  S  28  1  41  2  ~ 37  S 
10  -6  32  S  32  2  32  S  31  S  41  S  S,  38  S 
10  -~  33  1  35  2  32  S  30  S  32  46  2 
! 
10  -8  35  S  32  2  34  2  31  2  44  S  139  S 
10-,  38  s  35  s  35  I  2  38  1  45  2  48  s 
10  -e  40  2  35  2  38  2  38  2  49  I  50  2 
I0  -~  44  2  37  5  39  ]  1  38  3  51  S  52  2 
i 
I0  -s  32  S  41  S  42  S  43  S  41  S 
10 -7  35  S  38  S  46  S  45  S  45  S  ~ 45  S 
10  -6  43  S  40  S  44  !  S  47  S  56  2  52  S 
10  -~  43  2  41  S  48  2  49  2  58  2  58  2 
I 
10  -8  41  S  45  S  41  S  37  S  41  2  39  2 
10  -7  45  2  47  2  43  2  45  S  41  S  39  2 
10  -6  47  2  49  S  44  2  46  2  41  3  ]42  2  ! 
10-"  50  2  52  S  45  2  49  S  46  1  46  S 
10  -s  38  S  36  2  49  I  2  44  2  54  2  55  S 
10  -7  47  2  45  S  52  2  52  S  55  2  57  S 
10  4  48  2  46  2  57  2  54  S  54  S  ]60  2 
10  -5  49  1  50  2  65  S  63  S  72  S  62  2 
10  -s  46  S  46  S  43  S  46  2  49  S  45  S 
10  -7  50  2  48  S  50  S  49  S  51  S  47  2 
10  -6  52  S  48  2  51  S  Sl  '  2  51  S  51  2 
10  -~  52  S  54  S  52  2  52  [  S  57  2  56  2 
i 
C  =  control.  E  =  treated  rat.  S  =  survived.  Number  =  died,--days. 
* Became ill but recovered. VICTOR ROSS 
TABLE I--Concluded 
Experiment  Dose 
lO-S 
I0-~ 
I0-~ 
I0-6 
IO-S 
10-~ 
10  4 
10-6 
Litter 1 
gm. 
36 
40 
42 
36 
39 
39 
47 
gm. 
1  40 
2  45 
2  48 
2  37 
S  39 
1  39 
2  41 
gm 
45 
46 
51 
56 
42 
44 
44 
46 
Litter 2 
C  E 
gm. 
2  44 
2  47 
2  49 
2  56 
S 
S  40 
2  40 
1  43 
g~,~. 
S  41 
S  47 
1  50 
S 
27 
2  32 
33 
37 
~tter  3 
C  E 
2  42 
2  ~ 
2  ~ 
47 
S  26 
S  29 
2  29 
S  31 
growth on each of 3 successive days.  The animals were tested 2 days after the 
3rd feeding.  3 out of 12 controls and 6 out of 12 treated rats succumbed (Table I). 
Experiment 8.--Each E rat was fed S.S.S. solution equivalent to 66 cc. growth 
on each of 3 successive days.  The test was done 2 days after the last feeding.  ? 
out of 11 treated animMs and all 10 controls died (Table I). 
Experiment 9.--Each E rat received S.S.S. solution equivalent to 66 cc. growth 
on each of 3 successive  days.  Test was done 2 days after the last dose.  6 out of 
12 controls and 5 out of 11 treated rats died (Table I). 
Out of an equal number of animals in the two groups (58), there were 
36 deaths among controls and 29 among the treated rats.  Although 
this shows a greater survival rate among the treated rats, the difference 
is too small to be regarded  as related  to the ingestion of the soluble 
specific substance. 
Feeding the Type III Specific Substance 
Experiment/.--Each E rat received 0.43 rag. on each of 2 successive days.  The 
test was done 3 days after the 2nd feeding.  Of 8 treated rats, 1 survived.  All 8 
controls died (Table II). 
Experiment 2.--Each E  rat received 0.5 nag. on 1 day followed by 0.45 nag. the 
next day.  Test was done 3 days after the 2nd dose.  3 out of 12 treated rats and 
1 of 12 controls lived (Table II). 
Experiment &--Each E rat received 0.5 nag. on each of 2 successive days.  Test 
was done 3 days after the 2nd feeding.  8 out of 12 treated rats and 1 of 12 controls 
survived (Table II). Resistance to Pneumococcus Type 
TABLE  II 
III, Following Ingestion  of the Soluble Specific 
Substance 
Experiment  c 
Dose 
co.  gm. 
10 -8  51 
10  -7  52 
10  -8  59 
10 -5  62 
i0  -s  431 
10  -7  491 
10 -8  57 
I0  -~  61 
10 -s  39 
10-'  45 
I0-5 
10  -s  38 
10  -7  39 
10  -0  I  40 
10  -8  481 
10-7 
10-*  471 
10 -5  49 
10  -s  t  33 
10  -7  34 
10  -8  36 
10  -5  37 
10  -s  ]  25 
10  -7  ]  27 
10"*  27 
10  -8  30 
Litter 1 
E  C 
gm 
63 
63 
64 
67 
5O 
53 
56 
62 
42 
44 
50 
53 
32 
36 
36 
50 
51 
52 
60 
36 
40 
42 
55 
26 
27 
27 
30 
Litter 2 
grn 
2  51' 
2  521 
2  63  ~ 
2  6~ 
2  40~ 
2  59  ~ 
2  6~ 
1  684 
S  371 
2  41: 
1  441 
1  49  ~ 
2  38  ~ 
2  37  ~ 
2  45~ 
2  45~ 
2  45  ~ 
2  47  e 
2  ~7~ 
2  51' 
2  32 
2  39 
1  39 
1  45 
S  19 
2  27 
1  27 
S  28 
S 
2 
2 
,  2 
gm.  gm. 
2  577  S 
2  64  ~  2 
2  68  ~  2 
2  76  s  2 
S  516  S 
2  537  2 
2  576  2 
1  63 s  1 
2  432  S 
I  439  S 
1  501  o  S 
1  504  2 
2  301  2 
2  364  2 
2  397  2 
S  493  2 
2  524  2 
2  531  2 
2  55  TM  2 
S  37  S 
2  38  S 
1  39  2 
1  48  2 
S  25  S 
S  29  S 
1  29  S 
1  30  1 
Litter 3 
c  .  E 
gm. 
48  2  539  S 
52  2  62  '°  2 
54  2  64  al  2 
56  2  692  1 
46  [  2  40  S 
47  [  1  47  s  S 
48  [  1  486  2 
58  1  52  s  2 
40  2  3712  2 
41  2  429  2 
46  2  49  t°  2 
174  2  48n  2 
2  45  ~  S 
57  [  2  512  2 
59  2  541°  2 
64  2  58  s  2 
47  2  41  S 
47  2  48  S 
47  2  51  2 
48[  1  51  1 
~58  222  S 
2  28  2 
1  29  1 
The figures appearing as exponents of the weights of the E  rats in the first five 
experiments above, identify the rats in Table II of the paper  "Fate of the orally 
administered soluble specific substances of  Pneumococcus Types  I,  II  and III," 
Reference  3.  Experiments  1,  2,  3,  4  and  5  above  correspond  to  Experiments 
9, 10, 11, 12 and 13, respectively, in that table. 
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Experiment 4.--Details same as in Experiment 3.  1 out of 11 treated rats lived. 
All 11 controls died (Table II). 
Experiment ~5.--Detafls same as in Experiment 3.  2  treated  animals and  1 
control out of 12 in each group survived (Table II). 
Experiment 6.--Each E  rat received 1 rag. on each of 2 successive days.  Test 
was done 3 days after the 2nd feeding.  5 treated and 1 control animal survived 
(Table  II). 
Experiment 7.--Each E rat received 0.5 mg. on each of 2 successive days.  Test 
was done 3 days after 2nd feeding.  9 treated rats and 5  controls survived.  In 
the 4th litter, which does not appear in the table, of 3 controls injected with 10  -s, 
TABLE  III 
Resistance to Pneumococcus Type II, Following  Ingestion of Type I Soluble Specific 
Substance 
Dose 
{:6, 
lO-S 
10-7 
10-6 
10-6 
lO-S 
10-7 
10-6 
10-6 
Weight  t 
g~. 
36 
39 
41 
41 
36 
39 
42 
55 
Litter 1  Litter 2  Litter 3 
E 
esult  Weight Result 
S  42  S 
1  43  S 
S  43  S 
S  46  1 
S  37  2 
2  39  2 
2  4~4  2 
1  47  2 
C  E 
Weight  Result Weight  Result 
gm.  g~. 
33  S  32  S 
33  S  34  S 
38  S  37  S 
44  S  44  2 
38  2  35  2 
43  2  39  S 
44  9  43  2 
45  1  44  2 
C  E 
Weight Result 
39  S 
44  S 
46  2 
56  1 
37  2 
38  S 
42  2 
51  2 
Weight Result 
g~. 
38  S 
46  S 
46  S 
49  2 
35  2 
36  2 
38  2 
44  1 
The upper and lower parts of this table 
at different times. 
give the data of two experiments done 
10  -v and 10  -6 cc. respectively, the 2 latter died.  Of 4 treated rats, injected with 
10  -8, 10  -v, 10  -6 and 10  -5 cc., the last 3 died.  10  -5 cc. might have killed a  control 
as well if one had been injected with this dose (Table II). 
Of a  total of 82  control rats,  9  survived.  Of 83  treated  animals, 
29  lived.  It  would  seem  therefore,  that  the  ingestion of  Type  III 
specific  substance  was  followed  by  an  increased  resistance  to  the 
homologous  organism. 
Since it had already been shown (2) that the immunity obtained by 
feeding  the  Types  I,  II  and  III  pneumococci was  type-specific,  it 8  ~NITY  TO  PNEU~OCOCCUS  II AND  IIl 
followed that  the  specific substances  would  act in  a  similar manner. 
Nevertheless,  several  experiments  were  done  to  confirm  this  belief. 
The purified soluble specific substance of Type I  pneumococcus used 
in the experiments described in the preceding paper (1), was fed to rats 
which were then tested for resistance to Types II and III pneumococci. 
Experiments  were  also  done  to  determine  whether  any  increased 
resistance to Type I  could be obtained by the oral administration  of 
the specific substances of Types II and III pneumococci. 
TABLE IV 
Resistance to Pneumococcus Type III, Following  Ingestion of Type I Soluble Specific 
Substance 
Litter 1  Litter 2  Litter 3 
Dose  C  E  C  E 
10-8 
10-7 
10"6 
I0  ~ 
lO-S 
10-~ 
10-6 
10-~ 
Weight  Result 
gm 
57  S 
57  2 
62  2 
69  2 
48  S 
49  2 
50  1 
55  1 
V 'elght Result 
gm. 
56  S 
58  S 
58  S 
59  2 
50  S 
53  S 
54  1 
57  2 
C  E 
Weight  Result  Weight Result 
gm.  gm. 
51  S  54 
55  2  62 
57  2  64 
69  2  70 
46  S  47 
51  S  53 
62  S  61 
64i 
Weight Result 
gm. 
55  S 
65  S 
67  S 
68  2 
35  * 
40  2 
46  2 
Weight Result 
g~. 
60  S 
62  2 
69  2 
75  2 
40  11 ° 
41  11  ° 
48  1 
The upper and lower parts of this table 
at different times. 
* Missing,  probably dead. 
° Heart blood  sterile. 
give the data of two experiments done 
Experiment/.--Each E rat was fed 0.5 rag. S.S.S. Type I on each of 2 successive 
days.  The test took place on 3rd day after the 2nd dose.  3 out of 12 rats in each 
group succumbed when tested with Type II pneumococcus (Table III, upper part). 
Experiment 2.--Each E rat received 0.5 mg. S.S.S. Type I, on each of 2 succes- 
sive days.  The test was done 2 days after the 2nd dose.  10 out of 12 controls and 
11 out of 12 treated rats died when tested with Type II pneumococcus (Table III, 
lower part). 
Judging  from  the  results  of  these  two  experiments  no  increased 
resistance  to  Pneumococcus  Type  II  followed  the  ingestion  of  the 
specific substance of Type I. WCTOR  ROSS  9 
Experiment 3.--Each E  rat was fed 0.5 rag. S.S.S. Type I  on each of 2 succes- 
sive days.  The test was done 3  days after the 2nd feeding.  7 controls and  7 
treated rats died out of 12 animals in each group, when injected with Type III 
pneumococcus (Table IV, upper part). 
Experiment 4.--Each E rat received 0.5 rag. S.S.S. Type I, on each of 2 succes- 
sive days.  Test was done 3 days after the 2nd dose.  5 out of 10 controls and 5 
out of 11 treated rats died when tested with Type III pneumococcus (Table IV, 
lower part).  The delayed deaths in the 3rd litter are counted as survivors in view 
of the fact that the heart blood was sterile. 
TABLE  V 
Resistance to Pneumococcus Type I Following  Ingestion of Type II Soluble Specific 
Substance 
Part 1  Part 2 
Dose  C  E  E 
¢$. 
10-9 
10-8 
10-7 
10  ~ 
10-6 
Weight 
gm, 
118 
125 
118 
135 
134 
152 
152 
156 
153 
Result  Weight 
gm. 
7  103 
4  118 
6  123 
2  124 
2  131 
3  135 
2  137 
2  140 
4  170 
Result 
S 
2 
5 
2 
4 
9 
7 
2 
2 
Weight 
gm. 
80 
85 
85 
93 
91 
92 
89 
98 
90 
C 
Result  Weight 
gm. 
S  75 
2  78 
2  79 
2  85 
2  81 
2  87 
2  87 
2  92 
2  89 
~es~t 
S 
2 
2 
4 
2 
2 
2 
2 
2 
Part 1 and Part 2 of this table give the dats of two experiments done at different 
times. 
There  is  thus  no  evidence  for protection  against  Type  III  pneu- 
mococcus when the soluble specific substance of Type I  is fed to rats. 
12 out of 22  controls and  12 out of 23 treated animals died. 
Experiment 5.--Each of 9 E rats was fed 0.5 nag. purified S.S.S. of Pneumococcus 
Type II on each of 2 successive days and was tested with Type I  pneumococcus 
3 days after the 2nd dose.  8 of these, and all 9 controls died (Table V,  Part 1). 
Experiment 6.--Each of 9  E  rats received 0.5 nag.  purified S.S.S.  of Type II 10  IMMUNITY  TO  PNEUMOCOCCUS  II  AND  III 
pneumococcus on each of 2 successive days and was tested 3 days after the  2nd 
feeding.  Only 1 survived  an injection  of Type I  pneumococcus.  A  control  rat 
survived the same quantity (Table V, Part 2). 
Experiment 7.--Each of 8 E rats was fed 0.5 rag. purified S.S.S. of Pneumococcus 
Type III, on each of 2 successive days and was tested 3 days after the 2nd dose for 
resistance  to Type I pneumococcus.  All the treated rats died of 1 or more fatal 
doses (Table VI, Part 1). 
Experiment 8.--Each of 8 E rats was fed 0.5 mg. purified S.S.S. of Type III on 
each of 2 successive days and was tested  3 days after the 2nd feeding.  A single 
fatal dose of Pneumococcus Type I, killed the treated animals (Table VI, Part 2). 
TABLE  VI 
Resistance to Pneumococcus Type I, Following  Ingestion of Type III Soluble Specific 
Substance 
I  Part 1  Part 2 
Dose  C  C 
We~ht  Re 
c~.  I  g~. 
10  -°  65 
68 
10  -a  70 
74 
10  -7  75 
74 
10  .-6  78 
81 
E 
dt  Weight  Result 
gm. 
69  2 
62  3 
69  2 
70  2 
71  2 
71  1 
80  2 
77  2 
Welg It 
g~ 
70 
74 
84 
82 
91 
95 
R~ 
E 
.lt  Weight  Result 
62  S 
73  2 
75  2 
74  3 
78  2 
82  2 
95  4 
87  2 
Parts 1 and 2 of this table  give the data of two experiments  done at different 
times. 
It is thus seen that no immunity against Type I  pneumococcus was 
obtained by feeding either the Type II or III soluble specific substance. 
DISCUSSION 
The  experiments  which have  been  done  do not present  any  clear 
evidence of an increased resistance to Pneumococcus Type II,  follow- 
ing the ingestion of the specific substance.  Out of 106 control animals, 
48 survived; out of 105 treated ones, 57 lived.  These  rats  comprised VICTOR  ROSS  11 
27  litters,  in  12  of  which  there  was  no  difference  in  survival  rate 
between controls and  treated  animals;  in 6  the controls had  a  lower 
mortality  than  the  experimental  rats,  and  in 9  the  reverse was  the 
case.  This numerical advantage in favor of the experimental animals 
is too slight to permit one to conclude that it was the result of feeding 
the soluble specific substance.  It is of interest to compare these figures 
with those obtained when the organisms  (both intact  and dissolved) 
were  fed.  Out  of  a  total  of  74  controls,  25  survived;  of  an equal 
number of treated  rats,  63 lived.  In all  the 19 litters  employed the 
survival rate was greater among the experimental rats. 
In the case of Type III, it appears that the resistance of rats to the 
pneumococcus was increased by feeding the soluble specific substance. 
Of 82 controls, 9 lived; out of 83 treated rats, 29 survived.  Of the 20 
litters used, there were 4 in which the number of survivors was alike 
in both groups, 1 in which it was greater among the controls and 15 in 
which  the  contrary was the  case.  (Litter 4  in  Experiment  7 is not 
counted.)  When the whole Type III cell and the dissolved organisms 
were fed the proportion of animals protected was greater.  Out of a 
total of 96 controls, 28 lived, and of 100 treated rats 79survived.  In 
all  9  litters  comprising  a  part  of these  tests,  the  survival  rate  was 
greater  among  the treated animals.  Although the higher percentage 
of  survivals  is  probably  accounted  for  partly  by  the  fact  that,  in 
general, larger animals were used, ~ (also reflected in a similar increase 
among  the  controls)  a  closer  comparison  of the  data  obtained  with 
animals  of the  same weights  reveals that  this  fact is not wholly re- 
sponsible,  and that  there is a  real difference in favor of the bacteria- 
feeding experiments.  The  same was found to be true in comparing 
the  effects obtained  with the  Type I  pneumococcus and  its  specific 
substance. 
In view of the fact that the active constituents in all three types of 
pneumococci are resistant to exposure to N/12 HC1 for 3 hours at room 
temperature, are soluble in bile salt solutions, pass readily through the 
Berkefeld filter  and  are  resistant  to  the  gastrointestinal  enzymes of 
the  rat,  and  because  these  characteristics  are  consistent  with  the 
properties of the contained polysaccharides,  it seems surprising  that 
2  The increased resistance to Types II and III pneumococci which appears with 
increasing age of the rat is discussed in Reference 2. 12  rM'MUNITY  TO  PNE~OCOCCUS  II AND  III 
Types I and III of the latter should be found to possess an immunizing 
action and that the Type II specific substance does not exert this effect. 
Assuming that  it is  the  specific polysaccharide which is  the  active 
constituent when the Type II  pneumococcus is  fed,  the absence of 
antigenic activity on the part of this substance in the purified form in 
which it was used in the present experiments may be owing to  an 
intramolecular rearrangement during  the  process  of  its  separation 
from the cell.  Such a  change, as well as the possible  presence of a 
second active component, was proposed to account for the  quantita- 
tive difference between the immunity obtained by feeding the whole 
organism and that which followed the ingestion of the specific  sub- 
stance of Type I  (1).  It might also  explain the similar larger pro- 
portion of animals immunized by the ingestion of the Type III pneu- 
mococcus than by feeding of its specific substance. 
SUMMARY 
1.  When the  soluble  specific substance of Type II pneumococcus 
was fed to rats, little or no increased resistance to the organism was 
obtained. 
2.  When the specific substance of Type III pneumococcus was fed, 
an  increased  resistance  to  the  virulent  organism  resulted.  The 
percentage of animals protected is  smaller than when the whole or 
the dissolved cell is fed. 
3.  When the specific polysaccharide of Type I was fed, no immunity 
against Type II or III was obtained, and the ingestion of the specific 
substances of Types II and III did not protect rats against the Type I 
organism. 
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